Epigenetic equilibrium in chromatinopathies: network instability in neurodevelopment

Chromatin-modifying systems regulate transcriptional programs essential for human neurodevelopment through dynamic modification of histones, DNA, and higher-order chromatin architecture. Pathogenic variants affecting these systems give rise to chromatinopathies, a heterogeneous group of disorders characterised by consistent neurological features, including intellectual disability, developmental delay, autism spectrum disorder, epilepsy, and language impairment, alongside directional variation in somatic traits such as growth and skeletal development. This discordance challenges linear genotype-phenotype models.

This conceptual review synthesises genetic, epigenomic, transcriptomic, cellular, neuroimaging, and electrophysiological evidence to develop an epigenetic equilibrium model. The model proposes that neurodevelopment depends on context-specific balance among activation-associated and repressive chromatin mechanisms. Deviation from this range disrupts transcriptional fidelity and neural network stability. The concepts of chromatin load, network capacity, and mirror endophenotyping are used to explain variable expressivity, direction-sensitive somatic phenotypes, and convergent neurological outcomes.

Despite molecular diversity, chromatinopathies converge neurologically due to disruption of transcriptional equilibrium. We introduce an epigenetic equilibrium model incorporating chromatin load, network capacity, and transcriptional dynamics. We further define mirror endophenotyping as a framework capturing reciprocal directionality of intermediate phenotypes across shared chromatin axes.

Chromatinopathies are best understood as systems-level disorders of transcriptional regulation rather than isolated molecular defects. This framework provides a unifying mechanistic explanation for phenotypic convergence across chromatinopathies and introduces a systems-level approach to diagnosis and therapy. This approach provides a foundation for precision neurology in neurodevelopmental disease.